Hinge Health (NYSE:HNGE) Issues Quarterly Earnings Results

Hinge Health (NYSE:HNGE) posted its earnings results on Monday. The company reported $0.71 EPS for the quarter, topping the consensus estimate of $0.27 by $0.44, FiscalAI reports. Hinge Health had a net margin of 21.02% and a return on equity of 73.91%. The firm had revenue of $234.97 million during the quarter. During the same period in the prior year, the business posted ($0.02) earnings per share. The company’s revenue for the quarter was up 52.4% on a year-over-year basis.

Here are the key takeaways from Hinge Health’s conference call:

• Q3 results exceeded expectations, with revenue up 52% year over year to $235 million, an 88% gross margin, a 33% operating margin, and $120 million in free cash flow. The company raised its full-year 2026 revenue guidance to $879 million–$881 million and operating income guidance to $266 million–$268 million.
• Commercial momentum accelerated, with contracted clients up 28% year over year to 3,270, nearly 1 million SMB lives added through Q3, and more than 10 million lives across over 800 clients gaining access to multiple Hinge Health products. Management also cited rising win rates, strong health-plan partnerships, and increased member enrollment and renewals.
• Early results from the Migraine Care Program were encouraging, including a 23% reduction in monthly migraine days, a 28% reduction in attack duration, and clinically meaningful HIT-6 improvements for more than half of surveyed members. Migraine access has expanded to roughly 9 million lives, with most launches expected in early 2027.
• Hinge plans to launch its integrated GI Care Program in summer 2027, but management expects the offering’s revenue contribution to become meaningful mainly in 2028. The company is currently selling Cylinder’s existing GI solution and has expanded its GI client base by approximately 40% since announcing the acquisition.
• President Jim Pursley will step down at year-end to spend more time with his family and join Hinge Health’s board, with Chief Commercial Officer Aaryn Pure taking over go-to-market leadership. Management characterized the transition as orderly, but the change introduces leadership-transition risk.

Hinge Health Stock Up 2.5%

NYSE:HNGE traded up $2.93 on Wednesday, hitting $119.77. The stock had a trading volume of 597,053 shares, compared to its average volume of 1,631,876. The business’s 50-day simple moving average is $99.21 and its two-hundred day simple moving average is $67.72. The stock has a market cap of $9.66 billion, a price-to-earnings ratio of 61.19 and a beta of 1.19. Hinge Health has a 52-week low of $30.08 and a 52-week high of $124.94.

Key Hinge Health News

Here are the key news stories impacting Hinge Health this week:

• Positive Sentiment: Third-quarter revenue rose 52.4% year over year to about $235 million, beating estimates, while EPS of $0.71 also exceeded consensus. Hinge Health raised its 2026 revenue outlook to $879 million–$881 million, above the roughly $858.5 million consensus; its fourth-quarter forecast also topped estimates. Hinge Health reports record third quarter 2026 financial results
• Positive Sentiment: Several firms raised price targets following the results. Truist lifted its target to $145, while Morgan Stanley, RBC, Canaccord and Stifel also increased targets and maintained positive ratings. Analysts increase forecasts after Q3 results
• Positive Sentiment: Management is expanding beyond musculoskeletal care, including plans for an integrated gastrointestinal program in 2027. Broader offerings could create additional growth opportunities, although the company is also considering hardware acquisitions. Hinge Health revenue growth and expansion plans
• Negative Sentiment: HNGE has climbed 156% year to date and is near its highs, prompting concerns that its valuation and expectations may be stretched. That could make the shares vulnerable to profit-taking even after strong results. Hinge Health stock looks stretched after its YTD run

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. Morgan Stanley boosted their price target on Hinge Health from $117.00 to $131.00 and gave the stock an “overweight” rating in a research report on Tuesday. Weiss Ratings downgraded Hinge Health from a “hold (c)” rating to a “hold (c-)” rating in a report on Thursday, October 8th. Royal Bank Of Canada increased their target price on Hinge Health from $110.00 to $135.00 and gave the stock an “outperform” rating in a research note on Tuesday. Robert W. Baird increased their price objective on shares of Hinge Health from $85.00 to $90.00 and gave the company a “neutral” rating in a research report on Tuesday, September 22nd. Finally, Canaccord Genuity Group lifted their target price on shares of Hinge Health from $105.00 to $134.00 and gave the stock a “buy” rating in a report on Tuesday. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $118.93.

Insider Buying and Selling

In other Hinge Health news, President James Pursley sold 33,000 shares of Hinge Health stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $88.05, for a total transaction of $2,905,650.00. Following the transaction, the president owned 706,235 shares of the company’s stock, valued at $62,183,991.75. The trade was a 4.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Daniel Perez sold 150,000 shares of the company’s stock in a transaction that occurred on Thursday, September 10th. The stock was sold at an average price of $89.44, for a total transaction of $13,416,000.00. Following the completion of the transaction, the chief executive officer owned 35,470 shares of the company’s stock, valued at approximately $3,172,436.80. The trade was a 80.88% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,024,581 shares of company stock valued at $95,632,761 over the last three months. 18.92% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Pictet Asset Management Holding SA boosted its position in shares of Hinge Health by 9.7% during the 3rd quarter. Pictet Asset Management Holding SA now owns 6,122 shares of the company’s stock valued at $595,000 after acquiring an additional 539 shares during the last quarter. Parallel Advisors LLC lifted its position in Hinge Health by 15.1% during the third quarter. Parallel Advisors LLC now owns 7,215 shares of the company’s stock valued at $702,000 after purchasing an additional 944 shares during the last quarter. Alps Advisors Inc. purchased a new position in shares of Hinge Health in the 3rd quarter worth $595,000. Ashton Thomas Private Wealth LLC purchased a new position in shares of Hinge Health in the 3rd quarter worth $458,000. Finally, CenterBook Partners LP bought a new stake in shares of Hinge Health in the 3rd quarter worth about $856,000.

About Hinge Health

Hinge Health is a digital healthcare company focused on musculoskeletal (MSK) conditions, including back and joint pain. The company provides virtual care programs designed to help members manage pain, improve mobility and reduce the need for more costly or invasive treatments.

Its platform combines personalized exercise therapy, behavioral support, education and access to clinical professionals. Hinge Health also uses technologies such as motion-sensing wearable devices and artificial intelligence to help guide exercises, monitor progress and tailor care plans to individual needs.

Hinge Health primarily serves employers and health plans, which offer its programs to eligible members in the United States.